- Home
- AVIR vs BYM Comparison
AVIR vs BYM Comparison
Compare AVIR & BYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- BYM
- Stock Information
- Founded
- AVIR 2012
- BYM 2002
- Country
- AVIR United States
- BYM United States
- Employees
- AVIR N/A
- BYM N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- BYM Investment Managers
- Sector
- AVIR Health Care
- BYM Finance
- Exchange
- AVIR Nasdaq
- BYM Nasdaq
- Market Cap
- AVIR 276.9M
- BYM 312.7M
- IPO Year
- AVIR 2020
- BYM N/A
- Fundamental
- Price
- AVIR $3.25
- BYM $11.31
- Analyst Decision
- AVIR Hold
- BYM
- Analyst Count
- AVIR 1
- BYM 0
- Target Price
- AVIR $6.88
- BYM N/A
- AVG Volume (30 Days)
- AVIR 178.7K
- BYM 60.2K
- Earning Date
- AVIR 11-07-2024
- BYM 01-01-0001
- Dividend Yield
- AVIR N/A
- BYM 4.49%
- EPS Growth
- AVIR N/A
- BYM N/A
- EPS
- AVIR N/A
- BYM N/A
- Revenue
- AVIR N/A
- BYM N/A
- Revenue This Year
- AVIR N/A
- BYM N/A
- Revenue Next Year
- AVIR N/A
- BYM N/A
- P/E Ratio
- AVIR N/A
- BYM N/A
- Revenue Growth
- AVIR N/A
- BYM N/A
- 52 Week Low
- AVIR $2.81
- BYM $9.30
- 52 Week High
- AVIR $4.60
- BYM $11.77
- Technical
- Relative Strength Index (RSI)
- AVIR 44.03
- BYM 35.60
- Support Level
- AVIR $3.10
- BYM $11.44
- Resistance Level
- AVIR $3.48
- BYM $11.64
- Average True Range (ATR)
- AVIR 0.13
- BYM 0.12
- MACD
- AVIR -0.01
- BYM 0.00
- Stochastic Oscillator
- AVIR 29.52
- BYM 10.53
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About BYM Blackrock Municipal Income Quality Trust of Beneficial Interest
Blackrock Municipal Income Quality Trust is a closed-end municipal bond fund. Its investment objective is to provide current income exempt from U.S. federal income taxes, including the alternative minimum tax. It trust invests in various sectors such as transportation, utilities, health, education, corporate, housing and others.